Inventor · disambiguated record
Heidi Lopez De Diego
Also filed as: DE DIEGO HEIDI LOPEZ
17 granted patents·1 pending application·103 citations·filing 2005–2023
93Inventor score
Files withH LUNDBECK AS9LUNDBECK & CO AS H6DE DIEGO HEIDI LOPEZ1NICOLAJSEN HENRIK VIGAN1ROCK MICHAEL HAROLD1
Top patents by PatentIndex Score
18 records- 0196US11858954B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2021·Granted Jan 2, 2024·8 cites·31 claims
- 0296US11130775B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2020·Granted Sep 28, 2021·14 cites·16 claims
- 0394US8969355B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Mar 3, 2015·15 cites·7 claims
- 0494US7648991B2Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazineLUNDBECK & CO AS H·Filed 2006·Granted Jan 19, 2010·29 cites·31 claims
- 0592US9125908B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·11 cites·10 claims
- 0691US9227946B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Jan 5, 2016·9 cites·5 claims
- 0791US9125909B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·9 cites·11 claims
- 0883US12421271B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 0974US8598348B2Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazineNICOLAJSEN HENRIK VIGAN·Filed 2010·Granted Dec 3, 2013·7 cites·9 claims
- 1073US10857149B2Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazineH LUNDBECK AS·Filed 2018·Granted Dec 8, 2020·0 cites·10 claims
- 1162US11279682B2Vortioxetine pyroglutamateH LUNDBECK AS·Filed 2019·Granted Mar 22, 2022·0 cites·10 claims
- 1261US8227607B2Processes for 4-((1R,35)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereofDE DIEGO HEIDI LOPEZ·Filed 2010·Granted Jul 24, 2012·1 cites·24 claims
- 1358US9725458B2Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumptionH LUNDBECK AS·Filed 2014·Granted Aug 8, 2017·0 cites·14 claims
- 1455US9938286B2Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumptionH LUNDBECK AS·Filed 2017·Granted Apr 10, 2018·0 cites·11 claims
- 1546US10287261B2Vortioxetine pyroglutamateH LUNDBECK AS·Filed 2016·Granted May 14, 2019·0 cites·12 claims
- 1645US8076320B2Crystalline forms of a pharmaceutical compoundROCK MICHAEL HAROLD·Filed 2005·Granted Dec 13, 2011·0 cites·14 claims
- 1745US2010105730A1Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidineLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
- 1838US10071963B2Polymorphic form of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of Alzheimer's diseaseH LUNDBECK AS·Filed 2015·Granted Sep 11, 2018·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Heidi Lopez De Diego files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →